AGARWALEYEBSEDR AGARWALS HEALTH CARE L· Healthcare ServicesHighNeutral
Announced Tue, 4 Aug, 2026 · 13:58 IST

Q1 FY27 revenue up 26% to Rs 614 Cr, PAT up 44.6% to Rs 55 Cr

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.9%Reaction day
₹482.00
prior close
₹493.15
announcement price
In-mkt
timing
Nifty Microcap 250market+0.4%+2.5% vs market
Hospital peers, median of 26sector+0.1%+2.8% vs sector

On the reaction day the stock moved 2.5 pts more than Nifty Microcap 250 and 2.8 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.9
10m
+0.6
15m
+0.1
30m
-0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.9+0.4+2.5+0.1+2.8
Next day
+7.3+1.7+5.5+0.0+7.3
2d
+10.6+2.1+8.5+0.2+10.4
3d
+13.6+2.1+11.5+1.2+12.3
4d
+16.7+2.1+14.7+1.0+15.7
5d
+12.8+1.9+10.9-0.7+13.5
1w
+4.9+2.4+2.4-2.2+7.0
15d
+3.3+3.0+0.3-1.5+4.8
1m
+6.7+3.7+3.0-2.9+9.6
2m
+0.4+1.6-1.2-9.2+9.6
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 results on Aug 4, 2026. Revenue from Operations rose 26% YoY to Rs 614 Cr; total income up 23.9% to Rs 620 Cr. EBITDA grew 25.2% to Rs 177 Cr with margin of 28.5%. PAT jumped 44.6% to Rs 55 Cr. Performed 91,082 surgeries and added 18 new facilities, taking network to 304. Also approved S.R. Batliboi as Statutory Auditors till 20th AGM, KPMG as Internal Auditors, and new step-down subsidiary in Nigeria.

Likely market impact

Strong growth across all metrics with record network expansion; positive for shareholders, new subsidiary signals overseas expansion